Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LINDE PLCLIN · Entity 2835 | Exec VP & Chief Legal Officer | March 10, 2026 | March 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LINDE PLC
Report date March 10, 2026 · Filed March 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 22,137.769 |
Reported balance
After 2026-03-10 transaction · row 1
1 source rowRow 1 · 2026-03-10 · Sale · Disposed 4,357 · Balance 22,137.769 F1: Sales made under a 10b5-1 plan entered into on August 22, 2025. |
| Ordinary SharesSEC Table I · non-derivative | Indirect401(k) | 2,944.983 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,944.983 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,830 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 1,830 F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis. F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,570 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 1,570 F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis. F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,613 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 1,613 F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis. F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $483.62 · Expires 2036-03-09 | Direct | 14,917 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 14,917 F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $468.77 · Expires 2035-03-07 | Direct | 11,326 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 11,326 F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07 | Direct | 10,345 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 10,345 F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07 | Direct | 11,085 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 11,085 F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $270.99 · Expires 2032-03-07 | Direct | 13,280 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 13,280 F10: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08 | Direct | 20,975 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 20,975 F11: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09 | Direct | 26,155 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 26,155 F12: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 852.647 |
Reported balance
Holding disclosure · report date 2026-03-10 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 852.647 F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis. F13: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Sales made under a 10b5-1 plan entered into on August 22, 2025.
F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
F10: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
F11: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
F12: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
F13: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PRAXAIR INC
Report date October 31, 2018 · Filed November 02, 2018
Section 16 reporting ended · disclosed 2018-11-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirect401(k) | 0 |
Reported balance
After 2018-10-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-10-31 · Disposition to issuer · Disposed 1,751.0307 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 2
1 source rowRow 2 · 2018-10-31 · Disposition to issuer · Disposed 2,944 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-10-31 · Disposition to issuer · Disposed 5,670 · Balance 0 F2: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-31 · Disposition to issuer · Disposed 3,174 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-31 · Disposition to issuer · Disposed 4,384 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-10-31 · Disposition to issuer · Disposed 3,246 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-10-31 · Disposition to issuer · Disposed 3,000 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $109.68 · Expires 2022-02-28 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-10-31 · Disposition to issuer · Disposed 2,560 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-10-31 · Disposition to issuer · Disposed 4,860 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-10-31 · Disposition to issuer · Disposed 7,465 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-10-31 · Disposition to issuer · Disposed 21,190 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-10-31 · Disposition to issuer · Disposed 44,665 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-10-31 · Disposition to issuer · Disposed 40,100 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2018-10-31 · Disposition to issuer · Disposed 38,800 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2018-10-31 · Disposition to issuer · Disposed 251.307 · Balance 0 F9: Conversion to Praxair Common Stock is on a l-for-1 basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F10: Deferred stock units ("DSUs") acquired by the reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
F2: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F9: Conversion to Praxair Common Stock is on a l-for-1 basis.
F10: Deferred stock units ("DSUs") acquired by the reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2018 Filed Feb 28, 2018 21:53 UTC | PRAXAIR INC PX · Entity 162268 | GrantStock Option (right to buy) · Derivative | 38,800 | $0.00 Strike: $154.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000021 · edgar.xml · derivative · entry 7 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,800 Underlying: Common Stock · 38,800 shares Expires 2028-02-27 F5 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:53 UTC | PRAXAIR INC PX · Entity 162268 | GrantCommon Stock | 5,670 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000021 · edgar.xml · nonDerivative · entry 4 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,614 F3 · shares: Restricted stock unit award granted on February 27, 2018, payable in shares of Praxair Common Stock, vesting 100% on February 27, 2021. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:53 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionPerformance Share Units · Derivative | 1,193 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000884905-18-000021 · edgar.xml · derivative · entry 6 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,193 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_price: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 24, 2015 (the "PSU"). F4 · price: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_date: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.expiration_date: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F1 · derivative.underlying_shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 24, 2015 (the "PSU"). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:53 UTC | PRAXAIR INC PX · Entity 162268 | GrantPerformance Share Units · Derivative | 1,193 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000021 · edgar.xml · derivative · entry 5 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,193 Underlying: Common Stock · 1,193 shares Expires not disclosed F4 · security: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_price: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · price: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_date: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.expiration_date: The PSU paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:53 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 374 | $155.62 | $58,201.88 |
DisclosureSEC source: 0000884905-18-000021 · edgar.xml · nonDerivative · entry 3 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,944 F2 · shares: Shares of common stock withheld from the PSU payout to cover tax withholdings. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:53 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 1,193 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000021 · edgar.xml · nonDerivative · entry 2 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 24, 2015 (the "PSU"). Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 13:36 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock · Derivative | 82.845 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000017 · edgar.xml · derivative · entry 3 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169.473 Underlying: Common Stock · 82.845 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a l-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. F2 · derivative.expiration_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:52 UTC | PRAXAIR INC PX · Entity 162268 | GrantStock Option (right to buy) · Derivative | 40,100 | $0.00 Strike: $118.71 | $0.00 |
DisclosureSEC source: 0000884905-17-000013 · edgar.xml · derivative · entry 6 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,100 Underlying: Common Stock · 40,100 shares Expires 2027-02-28 F4 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:52 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionPerformance Share Units · Derivative | 480 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000884905-17-000013 · edgar.xml · derivative · entry 5 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 480 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). F3 · price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.expiration_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F1 · derivative.underlying_shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:52 UTC | PRAXAIR INC PX · Entity 162268 | GrantPerformance Share Units · Derivative | 480 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000013 · edgar.xml · derivative · entry 4 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480 Underlying: Common Stock · 480 shares Expires not disclosed F3 · security: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.expiration_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:52 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 165 | $118.11 | $19,488.15 |
DisclosureSEC source: 0000884905-17-000013 · edgar.xml · nonDerivative · entry 3 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,125 F2 · shares: Shares of common stock withheld from the PSU payout to cover tax withholdings. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:52 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000013 · edgar.xml · nonDerivative · entry 2 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). Read SEC document |
| February 23, 2016 Filed Mar 1, 2017 22:52 UTC | PRAXAIR INC PX · Entity 162268 | GrantStock Option (right to buy) · Derivative | 44,665 | $0.00 Strike: $102.22 | $0.00 |
DisclosureSEC source: 0000884905-17-000013 · edgar.xml · derivative · entry 11 Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,665 Underlying: Common Stock · 44,665 shares Expires 2026-02-23 F8 · derivative.exercise_date: This option vests over three yeras in three consecutive equal annual installments beginning on February 23, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.